Shu‐Min Lin
- Anesthesiology and Pain Medicine top 0.5%
- Developmental Neuroscience top 2%
-
- Air Quality and Health Impacts 25
- Immunology top 5%
- Immune Response and Inflammation 10
-
- Tracheal and airway disorders 21
- Respiratory Support and Mechanisms 17
- Lung Cancer Diagnosis and Treatment 12
-
- Atmospheric chemistry and aerosols 16
-
- Asthma and respiratory diseases 16
-
- Sepsis Diagnosis and Treatment 10
Shu‐Min Lin
157 papers receiving 4.3k citations
Peers
Comparison fields: 5 of 165
- Critical Care and Intensive Care Medicine 610
- Anesthesiology and Pain Medicine 433
- Developmental Neuroscience 243
- Health, Toxicology and Mutagenesis 793
- Immunology 795
Countries citing papers authored by Shu‐Min Lin
This map shows the geographic impact of Shu‐Min Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shu‐Min Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shu‐Min Lin more than expected).
Fields of papers citing papers by Shu‐Min Lin
This network shows the impact of papers produced by Shu‐Min Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shu‐Min Lin. The network helps show where Shu‐Min Lin may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Shu‐Min Lin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2024 | 1 | |
| 4 | 2024 | 0 | |
| 5 | 2024 | 1 | |
| 6 | 2023 | 3 | |
| 7 | 2023 | 56 | |
| 8 | 2023 | 0 | |
| 9 | 2023 | 24 | |
| 10 | 2022 | 2 | |
| 11 | 2022 | 6 | |
| 12 | 2022 | 3 | |
| 13 | 2021 | 12 | |
| 14 | 2021 | 7 | |
| 15 | 2021 | 3 | |
| 16 | 2021 | 6 | |
| 17 | 2020 | 14 | |
| 18 | 2020 | 33 | |
| 19 | 2013 | 19 | |
| 20 | 2008 | 46 |
About Shu‐Min Lin
Shu‐Min Lin is a scholar working on Critical Care and Intensive Care Medicine, Health, Toxicology and Mutagenesis, Pulmonary and Respiratory Medicine, Microbiology and Immunology, having authored 172 papers that have together received 4.4k indexed citations. Recurring topics across this work include Air Quality and Health Impacts (25 papers), Tracheal and airway disorders (21 papers), Respiratory Support and Mechanisms (17 papers), Atmospheric chemistry and aerosols (16 papers), Asthma and respiratory diseases (16 papers), Lung Cancer Diagnosis and Treatment (12 papers), Immune Response and Inflammation (10 papers) and Sepsis Diagnosis and Treatment (10 papers). The work is most often cited by research in Critical Care and Intensive Care Medicine (610 citations), Anesthesiology and Pain Medicine (433 citations), Developmental Neuroscience (243 citations), Health, Toxicology and Mutagenesis (793 citations) and Immunology (795 citations). Shu‐Min Lin has collaborated with scholars based in Taiwan, China and United States. Frequent co-authors include Chun‐Hua Wang, Han-Pin Kuo, Horng-Chyuan Lin, Chien‐Da Huang, Chien-Ying Liu, Fu‐Tsai Chung, Hezhong Tian, Xiaoxuan Bai, Shuhan Liu and Yueh‐Fu Fang. Their work appears in journals such as The Science of The Total Environment, Medicine, PLoS ONE, Environmental Pollution and The American Journal of the Medical Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.